According to the study, patients who received CBD treatment exhibited over 45 percent mean reduction in seizures, and researchers were outspoken in support of further research.
Articles
ChineseInvestors.com (CIIX) Takes Aim at North American, Chinese Cannabidiol Markets
ChineseInvestors.com, Inc. (OTCQB: CIIX) is offering a unique opportunity for investors as the company pursues a multi-pronged approach to conquering the rapidly expanding global markets in cannabidiol products and the medical marijuana space in Canada. The company aims to be the world’s leading publicly traded Chinese nutritional company.
India Globalization Capital, Inc. (NYSE: IGC) Aims to Become a Leading Provider of Cannabis-Based Combination Therapies
India Globalization Capital, Inc. (NYSE MKT: IGC) has set a long-term goal for itself in the U.S. of becoming a leading provider of cannabis-based pharmaceutical and nutraceutical products.
Marijuana Industry Growth Fueled by Investments and Public Support for Legalization
With the market expanding and public support increasing, there are more opportunities to invest than ever before.
India Globalization Capital, Inc. (NYSE: IGC) Management Quoted in “HIGH TIMES” Article
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the publication of “Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work” on August 1, 2017, by Javier Hasse on the website of “HIGH TIMES,” a publication that’s served as the preeminent source for cannabis information since 1974.
MYM Enters Into Agreement With Engineering Firm to Conduct Environmental Tests for Weedon, QC Project
MYM Nutraceuticals Inc. , (CSE: MYM) (OTC: MYMMF), is pleased to announce that it has reached an agreement with BIGIS Expert Conseils of Weedon, QC to conduct environmental tests for the Weedon project. The initial agreement will see BIGIS Expert Conseils conduct environmental tests for phases one and two of the Weedon project.
Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Clinical Study Agreement with
Medical Marijuana, Inc. (OTC: MJNA), today announced that its major investment company AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC: AXIM) has entered into a Clinical Study Agreement (CSA) with the University of British Columbia in Canada to begin a clinical trial with its CanChew Plus® cannabidiol chewing gum.
ABcann Global Corporation (TSX.V: Abcn) (OTCQB: Abccf) Announces Close of $15 Million Investment from Cannabis Wheaton
ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the completion of Cannabis Wheaton Income Corp.’s (TSX.V: CBW) previously detailed purchase of $15 million of ABcann common shares at an agreed upon valuation of $2.25 per share.
ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) Announces Close of $15 Million Investment from Cannabis Wheaton
ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the completion of Cannabis Wheaton Income Corp.’s (TSX.V: CBW) previously detailed purchase of $15 million of ABcann common shares at an agreed upon valuation of $2.25 per share.
Senate Appropriations Committee Action Adds Fuel to the Fire for Businesses in the Legal Cannabis Space
Proponents of legal cannabis celebrated a victory on July 27. By voice vote, the Senate Appropriations Committee approved a budget bill amendment that prevents the federal government from interfering in medical marijuana programs in states where cannabis has been legalized for medical use1.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Spotlighted by Technical420
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, including cannabinoids, was recently spotlighted in an article on Technical420.com.
India Globalization Capital, Inc. (NYSE: IGC) Adds Dr. Chuanhai Cao to Medical Research Team
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that Dr. Chuanhai Cao has joined its medical research team as a key advisor.
Medical Marijuana, Inc. Subsidiary Kannaway® Announces July 25, 2017 Largest Revenue Day in Company History
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that its subsidiary Kannaway® achieved the largest revenue in a single day on July 25, 2017 , in the Company's history. Kannaway® is the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products.
Marijuana Company of America Announces a $5 Million Fixed Funding Commitment
MARIJUANA COMPANY OF AMERICA, INC; (OTC PINK: MCOA), an innovative cannabis and hemp marketing and distribution company, announced today that it has signed an investment agreement with Tangiers Global, LLC ('Tangiers') for a Fixed Funding Commitment which will provide the Company with an equity investment of up to $5 million.
ChineseInvestors.com, Inc. (CIIX) Announces Establishment of Hemp Education Center
Through this club-style education center, the company aims to provide valuable information to those who want to learn more about the potential health benefits of non-industrial hemp and hemp-derived cannabidiol (CBD).